These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Gu L, Chen H, Tuo J, Gao X, Chen L. Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960 [Abstract] [Full Text] [Related]
5. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. Yamada K, Sakurai E, Itaya M, Yamasaki S, Ogura Y. Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519 [Abstract] [Full Text] [Related]
6. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S. Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297 [Abstract] [Full Text] [Related]
15. Hyperglycemia promotes vasculogenesis in choroidal neovascularization in diabetic mice by stimulating VEGF and SDF-1 expression in retinal pigment epithelial cells. Cai Y, Li X, Wang YS, Shi YY, Ye Z, Yang GD, Dou GR, Hou HY, Yang N, Cao XR, Lu ZF. Exp Eye Res; 2014 Jun; 123():87-96. PubMed ID: 24780853 [Abstract] [Full Text] [Related]
20. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor. Wakusawa R, Abe T, Sato H, Sonoda H, Sato M, Mitsuda Y, Takakura T, Fukushima T, Onami H, Nagai N, Ishikawa Y, Nishida K, Sato Y. Invest Ophthalmol Vis Sci; 2011 May 17; 52(6):3272-80. PubMed ID: 21345982 [Abstract] [Full Text] [Related] Page: [Next] [New Search]